ClinicalTrials.gg
CompletedNCT07352839Updated Jan 20, 2026

Brachial Plexus Block vs General Anesthesia in Upper Extremity Surgery

An interventional study of Brachial Plexus Block and General Anesthesia in Upper Extremity Surgery, Regional Anesthesia and General Anesthetic, sponsored by Adana City Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-20.

Sponsored by Adana City Training and Research Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled May 2025, registered Dec 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study compares two different anesthesia methods for upper arm and hand surgery: regional anesthesia (brachial plexus block) versus general anesthesia.

Regional anesthesia numbs only the arm being operated on by injecting local anesthetic near the nerves, while the patient remains awake or lightly sedated. General anesthesia puts the patient completely asleep using medications given through a breathing tube.

The main goals of this study are to compare:

  • How much pain patients experience after surgery
  • Patient satisfaction with their anesthesia
  • Side effects such as nausea, vomiting, or breathing problems
  • Time until patients are ready to go home
  • Overall safety of each method

Participants in this study will be randomly assigned to receive either brachial plexus block or general anesthesia for their scheduled upper extremity surgery. The research team will monitor participants during surgery and follow their recovery for 24 hours after the operation.

This research will help doctors and patients make better-informed decisions about which type of anesthesia may be best for upper extremity procedures.

02

Conditions studied

  • Upper Extremity Surgery
  • Regional Anesthesia
  • General Anesthetic
03

In context

Lead sponsor

Adana City Training and Research Hospital is the lead sponsor of 18 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • clusion Criteria:
  • Adults aged 18-65 years
  • I-II
  • Scheduled for elective upper-extremity orthopedic surgery
  • Able to provide
  • Able to understand and complete study questionnaires

Exclusion criteria

Exclusion Criteria:

  • to regional anesthesia
  • Coagulopathy or bleeding disorders
  • Local infection at the block site
  • Patient refusal of regional anesthesia
  • Known allergy to local anesthetic agents
  • Chronic opioid use (daily use for >3 months)
  • Psychiatric disorders preventing cooperation or consent
  • Pregnancy or breastfeeding
  • Severe respiratory disease (for general anesthesia group)
  • Pre-existing neurological deficit in the operative extremity
  • Emergency surgery
  • III or higher
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Active comparator
    Brachial Plexus Block Group

    Patients receiving ultrasound-guided brachial plexus block for upper extremity surgery

    Procedure: Brachial Plexus Block

  • Active comparator
    General Anesthesia Group

    Patients receiving general anesthesia for upper extremity surgery

    Procedure: General Anesthesia

Interventions

  • ProcedureBrachial Plexus Block

    Ultrasound-guided infraclavicular brachial plexus block using local anesthetic (e.g., ropivacaine or bupivacaine). Block performed before surgery to provide regional anesthesia for upper extremity surgery.

  • ProcedureGeneral Anesthesia

    Standard general anesthesia with intravenous induction and maintenance with volatile anesthetics or total intravenous anesthesia (TIVA). Endotracheal intubation or laryngeal mask airway used as appropriate.

06

What researchers measure

Primary outcomes

  1. Preoperative Anxiety Score

    Preoperative anxiety measured immediately prior to operating room entry using the State-Trait Anxiety Inventory-State (STAI-S) scale. STAI-S is a validated 20-item questionnaire assessing current state anxiety. Scores range from 20 to 80, with higher scores indicating greater anxiety levels.

    Time frame: Immediately before operating room entry (preoperatively)

Secondary outcomes

  1. Postoperative Pain Score

    Pain intensity measured using Visual Analog Scale (VAS) at multiple time points after surgery. VAS scores range from 0 to 10, where 0 indicates no pain and 10 indicates worst pain imaginable. Lower scores indicate better outcome.

    Time frame: From end of surgery to 24 hours postoperatively

  2. Opioid Consumption

    Total opioid consumption measured as morphine equivalent dose (mg) during the postoperative period. All opioid medications administered were converted to morphine equivalents using standard conversion factors. Lower consumption indicates better outcome.

    Time frame: From end of surgery to 24 hours postoperatively

  3. Number of Participants with Postoperative Nausea and Vomiting (PONV)

    Number of participants experiencing postoperative nausea and/or vomiting requiring antiemetic treatment during the postoperative period. PONV was defined as any episode of nausea or vomiting reported by the patient or requiring rescue antiemetic medication.

    Time frame: First 24 hours postoperatively

  4. PACU Length of Stay

    Duration of stay in the Post-Anesthesia Care Unit (PACU) measured in minutes, from admission to discharge readiness based on standardized discharge criteria (Aldrete score ≥9). Shorter stay indicates better recovery.

    Time frame: From PACU admission until discharge readiness (typically 0-4 hours postoperatively

  5. Quality of Recovery (QoR-15) Score

    Patient-reported quality of recovery assessed using the validated Quality of Recovery-15 (QoR-15) questionnaire. QoR-15 is a 15-item instrument measuring five dimensions of recovery: physical comfort, emotional state, psychological support, physical independence, and pain. Each item is scored 0-10, with total scores ranging from 0 to 150. Higher scores indicate better quality of recovery.

    Time frame: 24 hours postoperatively

  6. Patient Satisfaction Score

    Overall patient satisfaction with anesthesia care measured using a numerical rating scale from 0 to 5, where 0 indicates completely dissatisfied and 5 indicates completely satisfied. Patients were asked to rate their overall satisfaction with the anesthesia experience.

    Time frame: 24 hours postoperatively

07

Study locations

1 site
  • Adana City Training and Research Hospital
    Adana, Adana 01150, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Nov 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2025
First posted
Jan 20, 2026
StartActual
May 9, 2025
Primary completionActual
Nov 3, 2025
CompletionActual
Nov 4, 2025
Last update
Jan 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07352839
Lead sponsor
Adana City Training and Research Hospital
Responsible party
Dilek Uçak (Principal Investigator, Department of Anesthesiology and Reanimation, Adana City Training and Research Hospital) — Principal investigator
First posted
Jan 20, 2026
Start date
May 9, 2025
Primary completion
Nov 3, 2025
Completion
Nov 4, 2025
Last update
Jan 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion